YM 202074

Catalog No. :
ACMZJW632
CAS No. :
299900-84-8
Molecular Formula :
C56H72N8O16S2
Molecular Weight :
1177.37

IUPAC Name:N-cyclohexyl-6-(((2-methoxyethyl)(methyl)amino)methyl)-N-methylbenzo[4,5]imidazo[2,1-b]thiazole-2-carboxamide sesquifumarate

YM 202074 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameYM 202074
IUPAC NameN-cyclohexyl-6-(((2-methoxyethyl)(methyl)amino)methyl)-N-methylbenzo[4,5]imidazo[2,1-b]thiazole-2-carboxamide sesquifumarate
MDL No.MFCD18086871
Molecular FormulaC56H72N8O16S2
Molecular Weight1177.37
SMILESO=C(C1=CN2C3=CC(CN(CCOC)C)=CC=C3N=C2S1)N(C4CCCCC4)C.O=C(O)/C=C/C(O)=O.O=C(C5=CN6C7=CC(CN(CCOC)C)=CC=C7N=C6S5)N(C8CCCCC8)C.O=C(O)/C=C/C(O)=O.O=C(O)/C=C/C(O)=O
InChI KeyHABHEZNVNBKOQJ-VQYXCCSOSA-N
SynonymN-cyclohexyl-6-{[(2-methoxyethyl)(methyl)amino]methyl}-N-methylthiazolo[3,2-a]benzimidazole-2-carboxamide;YM-202074 sesquifumarate salt hydrate;N-Cyclohexyl-6-[[N-(2-methoxyethyl)-N-methylamino]methyl]-N-methylthiazolo[3,2-a]benzoimidazole-2-carboxamidesesquifumarate;N-cyclohexyl-7-[[2-methoxyethyl(methyl)amino]methyl]-N-methyl-[1,3]thiazolo[3,2-a]benzimidazole-2-carboxamide
CAS No.299900-84-8

Synthetic Route by SureRoute

1. ACMZJW632 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMZJW632 route product structure diagram
    ACMZJW632299900-84-8
Inquiry

2. ACMZJW632 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOHPB012 route compound structure diagram
    ACOHPB01238256-93-8 In Stock
  4. Then
  5. ACMZJW632 route product structure diagram
    ACMZJW632299900-84-8
Inquiry

Comments (0)